Article info

Download PDFPDF

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug

Authors

  1. Correspondence to Michael W Stewart, Associate Professor and Chairman, Department of Ophthalmology, Mayo Clinic Florida, 4500 San Pablo Rd., Jacksonville, FL 32224, USA; stewart.michael{at}mayo.edu
View Full Text

Citation

Stewart MW
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug

Publication history

  • First published March 23, 2012.
Online issue publication 
August 31, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.